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Abstract
Background: Many studies have assessed the volume-outcome relationship in cancer patients, but most focused
on better outcomes in higher volume groups rather than identifying a specific threshold that could assist in clinical
decision-making for achieving the best outcomes. The current study suggests an optimal volume for achieving good
outcome, as an extension of previous studies on the volume-outcome relationship in stomach cancer patients.
Methods: We used National Health Insurance Service (NHIS) Sampling Cohort data during 2004–2013, comprising
healthcare claims for 2550 patients with newly diagnosed stomach cancer. We conducted survival analyses adopting
the Cox proportional hazard model to investigate the association of three threshold values for surgical volume of
stomach cancer patients for cancer-specific mortality using the Youden index.
Results: Overall, 17.10% of patients died due to cancer during the study period. The risk of mortality among patients
who received surgical treatment gradually decreased with increasing surgical volume at the hospital, while the risk of
mortality increased again in “high” surgical volume hospitals, resulting in a j-shaped curve (mid-low = hazard ratio
(HR) 0.773, 95% confidence interval (CI) 0.608–0.983; mid-high = HR 0.541, 95% CI 0.372–0.788; high = HR 0.659,
95% CI 0.473–0.917; ref = low). These associations were especially significant in regions with unsubstantial surgical
volumes and less severe cases.
Conclusion: The optimal surgical volume threshold was about 727.3 surgical cases for stomach cancer per
hospital over the 1-year study period in South Korea. However, such positive effects decreased after exceeding a
certain volume of surgeries.
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Background
Cancer is the most common health issue in South Korea
due to its aging population, in which the prevalence rate
of chronic diseases has been increasing [1]. To reduce
problems related to cancer, many studies have been con-
ducted and treatment strategies, such as endoscopic pro-
cedures, surgery, chemotherapy, and radiotherapy that
considers a patient’s condition according to each cancer
stage, were developed [2, 3]. Hence, survival rates of
cancer patients showed a rapid increase of about 25%
over the recent decade, and cancer is increasingly being
considered as a type of chronic disease that requires
timely diagnosis and treatment rather than as an incur-
able disease [4]. Nevertheless, cancer incidence has gen-
erally increased, and it remains as the most frequent
cause of death (age-standardized mortality rate 90.2 per
100,000; 27.6% of all deaths in 2012) [4]. Among all
types of cancer, stomach cancer is the second most fre-
quent and the third highest causes of death in South
Korea (age-standardized incidence rate 39.9 per 100,000
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in 2012; age-standardized mortality rate 11.2 per 100,000
in 2012) [4]. Given the high frequency and mortality of
stomach cancer compared to other cancers, it is neces-
sary to devise effective alternatives for managing South
Korean stomach cancer patients.
Stomach cancer is usually treated by surgical treat-
ment rather than by chemotherapy or radiotherapy [5].
Previous surgical studies proposed many theories and al-
ternatives to achieve better surgical outcomes, and the
volume-outcome relationship was described in most
cases. This was because physicians or hospital personnel
who treat more surgical cases can develop their skills,
resulting in better outcomes, although an excessive vol-
ume could lead to negative outcomes [6]. Given that the
number of cancer patients in early stages of the disease
has gradually increased due to new medical technologies
and screening methods, the number of patients who
undergo surgical treatment has also increased [7–9].
Therefore, many studies focusing on the volume-
outcome relationship for cancer patients have been pub-
lished [10–12]. However, most of the previous studies
focused on better outcomes in higher volume groups,
rather than suggesting a specific volume threshold that
can guide clinical decision-making to improve outcomes.
In addition, only a few studies are available regarding
the volume-outcome relationship for cancer patients in
South Korea and other Asian countries. Therefore, we
investigated the relationship between surgical volume
for stomach cancer patients and mortality as an
extension of previous studies on the volume-outcome
relationship in cancer patients, using nationally repre-
sentative data in South Korea. Our findings suggest an
optimal volume for achieving good outcomes for stom-
ach cancer patients, and the results may assist in the
clinical decision-making and establishment of effective
health policies.
Methods
Database and data collection
We used the National Health Insurance Service (NHIS)
Sample Cohort data during 2002–2013 in this study.
This data included a 1,025,340 population which was
collected through a systematic sampling to extract a
2.2% nationally representative sample among 46,605,433
Koreans in 2002, and it included all healthcare claims
that were filed during 2002 to 2013. To analyze the rela-
tionship of stomach cancer surgical volume for cancer-
specific mortality, we only included patients with newly
diagnosed stomach cancer (International Classification
of Diseases (ICD)-10: C16) and undergoing gastrectomy
as their first treatment since 2004. Finally, the data used
in this study were from 2550 newly diagnosed stomach
cancer patients who received surgical treatment from
2004 to 2013.
Variables
The dependent variable used in this study was mortality
of patients with newly diagnosed stomach cancer
(ICD-10: C16). It was defined as cancer-specific mortality
in patients with stomach cancer. We selected the first date
of each patient’s hospital visit regardless of types of visits
and followed the stomach cancer patient. Patient mortality
in the study population was assumed to be the result of
worsening status due to cancer.
The interesting variable in this study was surgical vol-
ume for stomach cancer patients at each hospital over a
1-year period. To identify the threshold for optimal sur-
gical volume in a positive volume-outcome relationship,
we analyzed the optimal cutoff value of surgical volumes
to achieve an efficient volume-outcome relationship
related to cancer-specific mortality, using the Youden
index (sensitivity + specificity − 1) and the formula shown
below. The Youden index is the maximum vertical dis-
tance between ROC and a diagonal line; it is the idea for
maximizing the difference between true positive and false
positive. The optimal cutoff refers to where the Youden
index is at its highest value [13–15].






P = probability at maximizing the Youden index; β0 =
intercept; β1 = coefficient of surgical volume.
Based on the cutoff volume, we categorized the surgi-
cal volume into two groups and then additionally calcu-
lated the cutoff values for each group. By estimation, we
selected the following threshold values: low (<3.0), mid-
low (3.0–16.0), mid-high (16.0–30.0), and high (>30.0).
We also adjusted other independent variables to
analyze the association between the surgical volume in
each hospital and the mortality of patients who under-
went surgical treatment for stomach cancer. Other inde-
pendent variables were sex, age, income level, types of
insurance coverage, types of surgery, types of treatment,
dissection of lymph node, Charlson Comorbidity Index
(CCI), region, and types of medical institution. We
divided the age groups by intervals of 10 years from 40
to 70 years to reflect the variety in patient outcomes ac-
cording to aging, and below 30 years and above 70 years
were merged, respectively. Types of insurance coverage
in South Korean were defined into three groups as med-
ical aid, National Health Insurance (NHI) employee in-
surance, or NHI self-employed insurance according to
the National Health Insurance act. Beneficiaries of NHI
employee insurance comprised of either workers or em-
ployers in workplaces and also included their family who
live together. They pay about 7% of their average salary
as premium, and the rates changed every year. Benefi-
ciaries of NHI self-employed insurance were people for
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whom the criteria for the NHI employee did not apply.
Their premium is accounted based on both their income
which does not occur in the workplace and their property.
Medical aid was applied to people with lower income com-
pared to government-defined poverty level and people with
a disability. They could be provided free medical care by
government funds. By those criteria of NHI benefit, the
type of insurance coverage could reflect the socioeconomic
status of South Koreans. To reflect the severity of stomach
cancer in patients, we included treatment variables. Types
of surgery were classified into total and subtotal gastrec-
tomy, as well as by whether lymph node dissection was
included [16, 17]. Types of treatment were classified into
surgery with chemotherapy and radiotherapy, surgery with
chemotherapy, surgery with radiotherapy, and only surgery
[18]. The CCI was calculated by weighting and scoring for
other comorbid conditions besides cancer [19]. Hospital
region was defined as hospitals that provided surgical treat-
ment for patients with stomach cancer in capital regions
(Seoul and Gyeonggi) and others [20].
Statistical analysis
In this study, we analyzed the descriptive statistics such
as frequency or percentages of the study population in a
categorical variable at the baseline of study, and then we
analyzed chi-square tests for categorical variables and
cancer-specific mortality. In continuous variables, we
showed the means and standard deviations as descriptive
statistics and also analyzed t tests by cancer-specific
mortality. For suggesting the differences of cancer-
specific survival times by the surgical volume groups, we
showed the Kaplan-Meier survival curves with log-rank
tests. Finally, to suggest the association of surgical vol-
ume in each hospital for cancer-specific mortality, we
analyzed survival analyses adopting the Cox proportional
hazard model while adjusting other covariates. Sub-
group analyses were also performed to investigate the
differences in the association of surgical volume for
cancer-specific mortality according to region and types
of surgery or treatment. SAS statistical software version
9.4 (Cary, NC) was used in all analyses of this study.
Results
There were 2550 patients with newly diagnosed stomach
cancer during 2004 to 2013. Overall, 17.10% of patients
died due to cancer over the study period. Stomach can-
cer patients who received surgical treatment at hospitals
with higher surgical volumes had lower mortality. Pa-
tients with vulnerable socioeconomic status, such as old
age or low finances, experienced higher mortality. With
regard to severity indicators, patients who received total
gastrectomy or complex therapy had higher mortality. In
addition, patients who died from cancer had higher CCI
scores (Table 1).
Kaplan-Meier survival curves with log-rank test for
suggesting cancer-specific survival time by the surgical
volume were shown in Fig. 1. The survival time from the
first diagnosis of stomach cancer to cancer-specific death
was shorter in patients who received surgical treatment
at hospitals with lower surgical volumes (P for log-rank
test <0.0001).
The results of survival analysis to analyze the associ-
ation between surgical volume and cancer-specific mor-
tality among patients with stomach cancer are shown in
Table 2. Although the risk of mortality among patients
who received surgical treatment gradually decreased
with increasing surgical volume, the mortality risk
increased again in “high” surgical volume hospitals,
producing a j-shaped curve (mid-low = hazard ratio (HR)
0.773, 95% confidence interval (CI) 0.608–0.983; mid-
high = HR 0.541, 95% CI 0.372–0.788; high = HR 0.659,
95% CI 0.473–0.917; ref = low). In addition, the risk of
morality from cancer was significantly different accord-
ing to severity indicators. Patients who received total
gastrectomy or complex therapy, including surgery, as
treatment for stomach cancer had a higher risk of
mortality, although stratifying by CCI was not statisti-
cally significant.
We also performed sub-group analyses to investigate
differences in the relationship between surgical volume
and cancer-specific mortality according to region and
types of surgery or treatment. The risk of mortality
gradually decreased with increasing surgical volume,
although some j-shaped curve trends were observed.
The reduction in mortality risk by higher surgical vol-
ume was greater in patients who received surgical treat-
ment at hospitals located outside the capital, as well as
in those who received subtotal gastrectomy or only
surgery (Fig. 2).
Discussion
As cancer patients were continuously increased, health-
care professionals have put a significant amount of effort
to achieve better surgical outcomes, including the
analysis of volume-outcome relationship. According to
previous studies, patients who received treatment at hos-
pitals with high surgical volume had better outcomes.
Although the authors of those studies suggested alterna-
tives to improve patient outcomes, only a few identified
threshold values for the volume-outcome relationship
[10, 11]. Therefore, to improve surgical outcomes, we in-
vestigated the relationship between surgical volumes that
were categorized by the Youden index and cancer-
specific mortality among patients with stomach cancer.
The risk of mortality from cancer was lower in hospi-
tals with higher surgical volumes, similar to previous
studies on the volume-outcome relationship; however,
such positive effects decreased after exceeding a certain
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Table 1 General characteristics of patients with stomach cancer at baseline and distribution of those by cancer-specific mortality
Variables Total Died Survived P value
N/mean %/SD N/mean %/SD N/mean %/SD
Sex
Male 1739 68.20 314 18.06 1425 81.94 0.0598
Female 811 31.80 122 15.04 689 84.96
Age (years)
−39 110 4.31 14 12.73 96 87.27 <0.0001
40–49 379 14.86 48 12.66 331 87.34
50–59 650 25.49 82 12.62 568 87.38
60–69 768 30.12 137 17.84 631 82.16
70+ 643 25.22 155 24.11 488 75.89
Income
−40 716 28.08 127 17.74 589 82.26 0.6956
41–70 678 26.59 113 16.67 565 83.33
71–90 692 27.14 124 17.92 568 82.08
91+ 464 18.20 72 15.52 392 84.48
Types of insurance coverage
Medical aid 87 3.41 23 26.44 64 73.56 0.0399
NHI, self-employed 915 35.88 162 17.70 753 82.30
NHI, employed 1548 60.71 251 16.21 1297 83.79
Year of surgery
2004 238 9.33 70 29.41 168 70.59 <0.0001
2005 244 9.57 59 24.18 185 75.82
2006 229 8.98 50 21.83 179 78.17
2007 216 8.47 60 27.78 156 72.22
2008 266 10.43 46 17.29 220 82.71
2009 252 9.88 48 19.05 204 80.95
2010 263 10.31 44 16.73 219 83.27
2011 288 11.29 26 9.03 262 90.97
2012 280 10.98 27 9.64 253 90.36
2013 274 10.75 6 2.19 268 97.81
Types of surgery
Total gastrectomy 552 21.65 174 31.52 378 68.48 <0.0001
Subtotal gastrectomy 1998 78.35 262 13.11 1736 86.89
Types of treatment
With chemotherapy and radiotherapy 44 1.73 27 61.36 17 38.64 <0.0001
With chemotherapy 373 14.63 178 47.72 195 52.28
With radiotherapy 9 0.35 7 77.78 2 22.22
Only surgery 2124 83.29 224 10.55 1900 89.45
Dissection of lymph node
Yes 2531 99.25 431 17.03 2075 81.98 0.3081
No 44 1.73 5 11.36 39 88.64
CCI 0.79 1.43 1.05 1.72 0.74 1.36 <0.0001
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level of surgical volume [10, 21]. Our findings may suggest
a guideline for maximizing the surgical outcomes of stom-
ach cancer patients. Hospitals with mid-high surgical vol-
umes had the best outcomes. Considering the fact that
data in this study were collected by a systematic sampling
method (about 2.2% of the entire population), the optimal
threshold of surgical volume was approximately 727.3
surgical cases for stomach cancer per hospital annually
(16.0 * 100/2.2 = 727.3). However, if surgical volume ex-
ceeded about 1363.6, the shown benefit disappeared.
The current study also revealed some interesting find-
ings by sub-group analyses. For instance, reductions in
mortality from cancer showed different trends according
to region, type of surgery, and type of treatment. The
volume-outcome relationship was only statistically sig-
nificant in hospitals outside the capital region. We
hypothesized that there were no specific differences in
surgical skills between hospitals in the capital area, since
all of the hospitals had substantial surgical volumes for
cancer and, therefore, sufficient experience [20, 22].




Low (N = 368) 436 17.10 59 13.53 377 86.47 <0.0001
Mid-low (N = 292) 357 14.00 40 11.20 317 88.80
Mid-high (N = 27) 1273 49.92 227 17.83 1046 82.17
High (N = 17) 484 18.98 110 22.73 374 77.27
Region of hospital
Capital area (N = 328) 951 37.29 150 15.77 801 84.23 0.1705
Others (N = 376) 905 35.49 286 31.60 1313 145.08
Types of medical institution
General hospital (N = 689) 2531 99.25 430 16.99 2101 83.01 0.0924
Hospital (N = 15) 19 0.75 6 31.58 13 68.42
Total 2550 100.00 436 17.10 2114 82.90
Fig. 1 Kaplan-Meier survival curves and log-rank test results comparing survival rates between patients with stomach cancer by surgical volume
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Table 2 Results of survival analysis using the Cox proportional hazard model to examine the association between surgical volume
and cancer-specific mortality
Variables Mortality due to cancer
HR 95% CI P value
Patient characteristics
Sex
Male 1.132 0.914 1.401 0.2571
Female 1.000 – – –
Age (years)
−39 1.000 – – –
40–49 1.036 0.568 1.892 0.9071
50–59 1.136 0.640 2.016 0.6640
60–69 1.805 1.031 3.162 0.0388
70+ 4.252 2.406 7.513 <.0001
Income
−40 1.033 0.755 1.412 0.8410
41–70 1.166 0.859 1.582 0.3249
71–90 1.077 0.797 1.455 0.6303
91+ 1.000 – – –
Types of insurance coverage
Medical Aid 1.393 0.863 2.247 0.1749
NHI, self-employed 0.991 0.808 1.217 0.9338
NHI, employed 1.000 – – –
Year of surgery
2004 1.000 – – –
2005 0.881 0.618 1.255 0.4818
2006 0.854 0.589 1.240 0.4078
2007 1.008 0.707 1.438 0.9640
2008 0.765 0.519 1.127 0.1752
2009 1.050 0.714 1.543 0.8043
2010 0.787 0.525 1.179 0.2460
2011 0.664 0.415 1.061 0.0868
2012 1.173 0.733 1.879 0.5060
2013 0.948 0.403 2.232 0.9032
Types of surgery
Total gastrectomy 2.228 1.823 2.724 <.0001
Subtotal gastrectomy 1.000 – – –
Types of treatment
With chemotherapy and radiotherapy 4.605 3.010 7.043 <.0001
With chemotherapy 6.139 4.935 7.636 <.0001
With radiotherapy 9.068 4.071 20.199 <.0001
Only surgery 1.000 – – –
Dissection of lymph node
Yes 0.983 0.403 2.398 0.9708
No 1.000 – – –
CCI 1.051 0.995 1.111 0.0739
Choi et al. World Journal of Surgical Oncology  (2017) 15:134 Page 6 of 9
Differences by the type of surgery or treatment may have
resulted as better surgical skills have less impact on se-
vere cases [16, 18]. Therefore, the positive effect of
higher surgical volume was only observed for patients
undergoing subtotal gastrectomy or only surgery. Based
on our results, health policymakers and healthcare pro-
fessionals may have to figure out alternatives or guide-
lines that can maximize patient outcomes.
Our study had some strengths. First, our data used a
national sampling cohort to investigate the association
between surgical volume for stomach cancer and cancer-
specific mortality. Thus, the results of this study would
be a positive role in making evidence-based cancer pol-
icies for optimal management of stomach patients who
require surgical treatment. Second, to suggest an optimal
threshold for surgical volume, we calculated the cutoff
value for surgical volume using the Youden index. This
enabled the selection of an optimal threshold for surgical
volume with the best outcomes for stomach cancer sur-
gery. Although a number of previous studies investigated
Table 2 Results of survival analysis using the Cox proportional hazard model to examine the association between surgical volume
and cancer-specific mortality (Continued)
Hospital characteristics
Hospital volume
Low 1.000 – – –
Mid-low 0.773 0.608 0.983 0.0356
Mid-high 0.541 0.372 0.788 0.0014
High 0.659 0.473 0.917 0.0135
Region of hospital
Capital area 1.131 0.924 1.385 0.2316
Others 1.000 – – –
Types of medical institution
General hospital 0.311 0.133 0.729 0.0072
Hospital 1.000 – – –
Fig. 2 Results of sub-group analyses for the relationship between surgical volume and mortality due to cancer according to hospital regions,
types of surgery, or types of treatment. The references level was low in surgical volume groups. *P < 0.1; **P < 0.05
Choi et al. World Journal of Surgical Oncology  (2017) 15:134 Page 7 of 9
surgical volume-outcome relationship in cancer, only a
few suggested a threshold volume for efficient outcomes.
Therefore, our findings may suggest helpful evidence-
based criteria or methods for the cancer policies for op-
timal management of cancer patients.
Our study also had some limitations. Cancer staging is
a major factor in cancer treatment, as it reflects severity
of cancer patients. Health outcomes of cancer patients
differ based on cancer staging, and a patient’s hospital
preference might also differ by their clinical severity.
However, we could not identify any information on can-
cer staging, including the SEER summary staging, due to
limitation of data [23]. To minimize such limitation, we
considered types of surgery, types of treatment during
treatment period of each patient, and dissection of
lymph node on surgery as covariates. Second, we only
included patients who received surgical treatment for
stomach cancer to avoid large differences in severity [2],
as healthcare claim data had no information on cancer
staging such as SEER. Third, given that the average
period from the first diagnosis of stomach cancer to
death was about 4 years, there were several potential
confounders related to disease management such as de-
tailed severity indicators, socioeconomic factors, or food
consumption. All of the listed factors have the potential
to influence health outcomes in patients undergoing
stomach cancer surgery, even with the inclusion of
variables such as the Charlson Comorbidity Index, which
reflects the clinical status of patients with gastric cancer
[24]. However, since our study used health insurance
claim data, which were collected to provide payment for
both patients and providers based on medical utilization,
we could not account for such confounders. Fourth, de-
tailed characteristics of hospital and human resources,
such as surgeon volume or surgeon experience, could
serve a positive role in cancer care, particularly for surgi-
cal outcomes. However, we could not consider such de-
tailed characteristics due to data limitation, despite
consideration of some hospital characteristics. Fifth, the
Health Insurance Review and Assessment (HIRA) in
South Korea initiated healthcare quality assessments for
managing gastric cancer patients after 2014. While posi-
tive impacts on quality of care are expected, the current
study was conducted before this program was applied.
Finally, South Korea is known to offer one of the world’s
best gastric cancer care systems, due to its relatively high
incidence and the corresponding burden of the disease.
Therefore, surgical volumes of gastric cancer may not be
generalized in other countries, and healthcare systems
and implementation of the recommended thresholds
may not be realistic. Nevertheless, suggestion of alterna-
tives in finding the optimal surgical volume for maximiz-
ing surgical outcomes can be helpful in establishing an
efficient healthcare policy or providing optimal case
management for cancer care [25]. Despite some limita-
tions, our findings suggested that cancer mortality
decreased in hospitals with higher surgical volumes, as
similarly stated in previous studies on the volume-
outcome relationship. However, such positive effects
decreased for very high-volume hospitals. These associa-
tions were especially significant in regions with low sur-
gical volumes and less severe cases. Although further
studies using more detailed data are required, our results
underscore the need for health policymakers and health-
care professionals to identify effective ways to improve
cancer management and reduce stomach cancer mortal-
ity in South Korea.
Conclusion
Higher surgical volume for stomach cancer is associated
with lower mortality. Our results suggest that the opti-
mal threshold of surgical volume for good outcomes was
about 727.3 surgical cases for stomach cancer per hos-
pital annually in South Korea, but such positive effects
decreased after exceeding a certain level of surgeries.
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